Hemoglobin Levels in Blood
Conditions
Keywords
Pronto-7, SpHb, Obstetric patients
Brief summary
The measurement of blood hemoglobin (Hb) concentration is a routine procedure in pregnant women. The assessment of Hb involves several steps, including a needle stick, blood collection, blood sample analysis in the laboratory, and waiting for the results. Pronto-7 (manufactured by Masimo, CA, USA) is a new portable device that allows a quick bedside Hb spot check. A finger clip probe, similar to the standard oxygen finger clip probe, provides hemoglobin values in less than 60 seconds. In this prospective observational study the investigators will assess the clinical accuracy of Pronto-7 derived Hb values compared to the gold standard laboratory Hb values in obstetric patients. We will be calculating the mean difference between Pronto-7 and laboratory Hb values. We plan to recruit 55 pregnant women admitted for vaginal or cesarean delivery at BC Women's Hospital.
Detailed description
Serum hemoglobin (Hb) concentration is one of the most common laboratory tests measured when a pregnant woman (parturient) is admitted for a vaginal or cesarean delivery. The Hb concentration is normally measured from a venous blood sample in clinical laboratories using co-oximetry. A new point-of-care pulse co-oximeter, the Pronto-7 (Masimo Corporation, Irvine, CA, USA), is a portable device that offers a non-invasive and quick spot-checking of Hb (SpHb). Measurement with the Pronto-7 takes about 60 seconds and does not require the transfer of blood samples to a laboratory. In addition to SpHb, the device provides a perfusion index (PI) value (a numeric estimation of the pulse strength at the measurement site), heart rate, oxygen saturation, and finger temperature. Potential advantages of the Pronto-7 include reduced staff work, decreased exposure to potential biohazards, and reduced pain and discomfort to the patient. A similar technology is used in Radical-7 pulse co-oximeter (Masimo Corporation, Irvine, CA, USA) for non-invasive Hb measurement. Radical-7 has been evaluated in human volunteers undergoing hemodilution, in patients undergoing spine surgeries, major urological procedures, and in critically ill patients. However, the results regarding the accuracy of this technology are conflicting.
Interventions
DEVICEPronto-7
A new point-of-care pulse co-oximeter that offers a non-invasive and quick spot-checking of Hb (SpHb).
Sponsors
Masimo Corporation
University of British Columbia
Study design
Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
FEMALE
Age
19 Years to 40 Years
Healthy volunteers
Yes
Inclusion criteria
* Are 19 - 40 years old * Understand written and oral English * Are greater than 37 weeks gestational age * Have a singleton pregnancy
Exclusion criteria
* Have a laboratory Hb less than 100 g/L * Have abnormal Hb disorders * Have hyperbilirubinemia * Have a peripheral vascular disease (e.g. Reynaud's syndrome) * Have long or acrylic nails
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Hemoglobin (Hb) value | 15-20 minutes before venipuncture | Difference between the pre-venipuncture SpHb values and the laboratory Hb values (SpHb-Lab Hb difference) measured from the same extremity of each subject |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Comparisons of SpHb values | 15-20 minutes before venipuncture and 15-20 minutes after venipuncture | Comparison between right and left hand SpHb values measured immediately before venipuncture. Comparison between right and left hand SpHb values measured immediately after venipuncture. Comparison of SpHb values measured from the same extremity immediately before and after venipuncture. Comparison of the SpHb-lab Hb differences between subjects in labour for vaginal delivery and subjects undergoing elective cesarean delivery. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Consistency of lab Hb results | 4 hours after venipuncture | Comparison between the first and second reading on the laboratory Cooximeter. |
Countries
Canada
Outcome results
None listed